Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$4.05 USD
-1.96 (-32.61%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $4.04 -0.01 (-0.25%) 7:58 PM ET
5-Strong Sell of 5 5
C Value B Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Ironwood Pharmaceuticals, Inc. [IRWD]
Reports for Purchase
Showing records 921 - 940 ( 1026 total )
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
New and Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
New and Recent Drug Launch Weekly Retail Sales Tracker - Week Ending Sept. 13
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
New and Recent Drug Launch Weekly Retail Sales Tracker - Week Ending Sept. 6
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
New and Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Aug. 23
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology/Biopharmaceuticals/BioDefense - New Drug Launch Weekly Retail Sales Tracker - Week Ended Aug. 9
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
New Drug Launch Weekly Retail Sales Tracker - Week Ended July 26
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Linzess Gains Traction, Beats Q2 Consensus, However High Cash Burn Remains Concerning; Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
New and Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Q2:13 EPS Preview: Linzess Growth Continues, But We View Shares As Fully Valued
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G